Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-13

Clinical Trial Update: Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services [NA]

View source ↗

Summary

This Yale University study is recruiting to test a stepped-care approach that combines contingency management with PrEP adherence and support services to reduce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PrEP (emtricitabine/tenofovir disoproxil fumarate) (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Yale University | Conditions: Opioid-use Disorder, HIV Prevention Program | NA | Status: RECRUITING